ResearcherAlbert Einstein College of MedicineNo recent work listed

Julius Strauss

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7550-4938; OpenAlex author ID A5033345547; NIH RePORTER profile ID 15201616. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 grant

Papers 2

Grants 1

Cancer Immunotherapy Clinical Trials ZIABC011547 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Christine Alewine · 1 shared paper, 2016 · strength 0.08
- Paper Targeting the microenvironment of pancreatic cancer: overcoming treatment barriers and improving local immune responses. DOI 10.1007/s12094-015-1459-8 ↗
William Douglas Figg · 1 shared paper, 2016 · strength 0.08
- Paper Targeting the microenvironment of pancreatic cancer: overcoming treatment barriers and improving local immune responses. DOI 10.1007/s12094-015-1459-8 ↗
Austin G. Duffy · 1 shared paper, 2016 · strength 0.08
- Paper Targeting the microenvironment of pancreatic cancer: overcoming treatment barriers and improving local immune responses. DOI 10.1007/s12094-015-1459-8 ↗
Ekaterina Dadachova · 1 shared paper, 2014 · strength 0.04
- Paper Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNA. DOI 10.1586/14737140.2014.952285 ↗
Ruth A. Bryan · 1 shared paper, 2014 · strength 0.04
- Paper Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNA. DOI 10.1586/14737140.2014.952285 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.